Vaccines Stocks List

Vaccines Stocks Recent News

Date Stock Title
May 2 MRK Cerevance receives milestone payment under Alzheimer's collaboration with Merck
May 2 ALT Altimmune to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
May 1 MRK 15 Best Places to Retire in Florida That You’ve Never Heard Of
May 1 NVAX How Is The Market Feeling About Novavax?
May 1 MRK Merck Keytruda combo meets main goal in late-stage trial for advanced gastric cancer
May 1 AGEN Agenus regains compliance with Nasdaq minimum bid price requirement
May 1 ALT Altimmune to Participate at Two Upcoming Conferences
May 1 AGEN Agenus Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 1 MRK Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Apr 30 AGEN Time Is Running Out For Agenus To Raise Cash
Apr 30 NVAX Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Apr 30 RENB Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
Apr 30 ALT Peering Into Altimmune's Recent Short Interest
Apr 30 MRK Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Apr 29 ALT Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Apr 29 MRK Merck late-stage data strengthens profile of pneumonia vaccine candidate
Apr 29 MRK Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults
Apr 29 NVAX 3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Apr 29 MRK Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
Apr 28 AGEN Up 40%: Is This Red-Hot Growth Stock Still a Buy?
Vaccines

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by a natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).The administration of vaccines is called vaccination. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world.
The effectiveness of vaccination has been widely studied and verified; for example, vaccines that have proven effective include the influenza vaccine, the HPV vaccine, and the chicken pox vaccine. The World Health Organization (WHO) reports that licensed vaccines are currently available for twenty-five different preventable infections.The terms vaccine and vaccination are derived from Variolae vaccinae (smallpox of the cow), the term devised by Edward Jenner to denote cowpox. He used it in 1798 in the long title of his Inquiry into the Variolae vaccinae known as the Cow Pox, in which he described the protective effect of cowpox against smallpox. In 1881, to honor Jenner, Louis Pasteur proposed that the terms should be extended to cover the new protective inoculations then being developed.

Browse All Tags